Find the latest news from Novozymes' news archive.
03 February 2016
Former Secretary General of NATO Anders Fogh Rasmussen and Novozymes’ CEO take steps to highlight Europe’s problematic addiction to oil – and what can be done about it
25 January 2016
The product Alterion is based on beneficial bacteria that improve feed utilization and provide a natural alternative to antibiotic growth promoters on poultry farms.
19 January 2016
Solid financial results in 2015; 2016 outlook of 8-10% growth in net profit despite expectations of a challenging year for sales growth
The new stand-alone company Albumedix will continue to develop albumin-based products and technologies for the pharmaceutical industry.
06 January 2016
Researchers from Monsanto and Novozymes see progress in U.S. field tests, plan to launch corn inoculant in 2017.
07 December 2015
The battle against climate change can be won by using existing technologies, establishing carbon pricing mechanisms, and phasing out inefficient fossil fuel subsidies.
24 November 2015
Paras Biopharmaceuticals partners with Novozymes in a feasibility study using VELTIS® technology to develop an improved version of a leading osteoporosis treatment.
17 November 2015
Scientific breakthroughs and new products are expected to significantly increase demand for microbial technologies over the next 10 years. Microbes can increase crop yields and complement or replace agricultural chemicals and fertilizers.
30 October 2015
Employees motivated by finding biological solutions to global challenges.
27 October 2015
A typical facility can increase annual returns by up to $2.5 million.
| Copyright © 2016 Novozymes. All Rights Reserved.